pyrroles has been researched along with Blue Toe Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Postema, PG; Regeer, MV; Richel, DJ; Stroes, ES; van der Valk, PR | 1 |
| Fujita, T; Hirata, Y; Matsumoto, A; Matsumura, T; Nagai, R; Ohno, M; Ohta, M; Suzuki, E; Suzuki, S; Takenaka, K | 1 |
2 other study(ies) available for pyrroles and Blue Toe Syndrome
| Article | Year |
|---|---|
Blue toe syndrome and sunitinib.
Topics: Antineoplastic Agents; Blue Toe Syndrome; Carcinoma, Renal Cell; Heparin, Low-Molecular-Weight; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Protein Kinase Inhibitors; Pyrroles; Sunitinib | 2011 |
A case of cholesterol embolism confirmed by skin biopsy and successfully treated with statins and steroids.
Topics: Aged; Atorvastatin; Biopsy; Blue Toe Syndrome; Diagnosis, Differential; Embolism, Cholesterol; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Prednisolone; Pyrroles; Simvastatin; Skin; Skin Diseases, Vascular; Steroids | 2006 |